Australia markets open in 3 hours 39 minutes

Fisher & Paykel Healthcare Corporation Limited (FPH.NZ)

NZSE - NZSE Delayed price. Currency in NZD
Add to watchlist
30.02+0.02 (+0.07%)
At close: 4:59PM NZDT
Currency in NZD

Valuation measures

Market cap (intra-day) 517.35B
Enterprise value 317.09B
Trailing P/E 33.26
Forward P/E 149.26
PEG ratio (5-yr expected) 142.17
Price/sales (ttm)8.95
Price/book (mrq)11.41
Enterprise value/revenue 38.77
Enterprise value/EBITDA 721.15

Trading information

Stock price history

Beta (5Y monthly) -0.18
52-week change 3-14.81%
S&P500 52-week change 330.48%
52-week high 337.19
52-week low 327.10
50-day moving average 331.85
200-day moving average 332.06

Share statistics

Avg vol (3-month) 3653.27k
Avg vol (10-day) 3381.93k
Shares outstanding 5577.01M
Implied shares outstanding 6N/A
Float 8574.18M
% held by insiders 16.46%
% held by institutions 129.70%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.38
Forward annual dividend yield 41.27%
Trailing annual dividend rate 30.38
Trailing annual dividend yield 31.27%
5-year average dividend yield 41.35
Payout ratio 434.85%
Dividend date 3N/A
Ex-dividend date 424 June 2021
Last split factor 25:1
Last split date 304 Oct 2004

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2021
Most-recent quarter (mrq)31 Mar 2021

Profitability

Profit margin 26.59%
Operating margin (ttm)36.13%

Management effectiveness

Return on assets (ttm)25.37%
Return on equity (ttm)42.03%

Income statement

Revenue (ttm)1.97B
Revenue per share (ttm)3.42
Quarterly revenue growth (yoy)53.10%
Gross profit (ttm)1.25B
EBITDA 781.3M
Net income avi to common (ttm)524.2M
Diluted EPS (ttm)0.90
Quarterly earnings growth (yoy)79.80%

Balance sheet

Total cash (mrq)377.6M
Total cash per share (mrq)0.65
Total debt (mrq)119.8M
Total debt/equity (mrq)7.88
Current ratio (mrq)2.15
Book value per share (mrq)2.64

Cash flow statement

Operating cash flow (ttm)625.3M
Levered free cash flow (ttm)340.26M